Lv414
630 积分 2024-01-12 加入
Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across IDH-stratified glioma
3天前
已完结
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
19天前
已完结
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
19天前
已完结
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
19天前
已完结
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
19天前
已完结
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
19天前
已完结
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
19天前
已完结
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
21天前
已完结
Palbociclib and Letrozole in Advanced Breast Cancer
21天前
已完结
First CDK 4/6 Inhibitor Heads to Market
21天前
已完结
皖公网安备34019202002308
